Incyte Corporation

Incyte Corporation

World Rank (Jul-30-2023)
1265
Market Cap (Jul-30-2023)
14.08 Billion USD
World Rank (Dec-25-2022)
918
Market Cap (Dec-25-2022)
18.10 Billion USD
World Rank (Jan-07-2022)
1,253
Market Cap (Jan-07-2022)
16.17 Billion USD
World Rank (Jan-01-2021)
950
Market Cap (Jan-01-2021)
19.05 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 494
Company Rank in Country in 2022
Rank in USA in 2022 is 511
CEO
Herve Hoppenot
Employee Count
2,324
Employee Count as of Date
As on 2022
Headquarters Country
USA
Headquarters City/State
Delaware
Annual Revenue in USD
3,394 Million USD
Annual Operating Income in USD
591 Million USD
Annual Net Income in USD
340 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
5,840 Million USD
Total Liabilities in USD
1,470 Million USD
Total Equity in USD
4,370 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector LC
Healthcare
Biopharmaceutical
Biotechnology
Pharmaceutical
HealthCare Products
Company Website
Incyte Corporation - Pharmaceutical Company
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Facebook
Facebook
Company Profile

Incyte Corporation is a Bio-Pharmaceutical company with headquarters in Delaware, USA.

As on 2021, Incyte Corporation has 2,094 employees, 989 are in research and development, 187 in medical affairs, 638 in sales and marketing and 280 in operations support, finance and administrative positions.

As on 2022, Incyte Corporation has 2,324 employees.

Incyte Corporation annual revenue generated for period ending Dec-2022 was 3,394 million USD.

Incyte Corporation annual net income generated for period ending Dec-2022 was 340 million USD.

Annual Results Summary LC

INCYTE CORPORATION - Annual Results Summary - in Million USD

Year Ending:Total RevenueGross ProfitOperating IncomeNet Income
Dec-20223,3943,187591340
Dec-20212,9862,856585948
Dec-20202,6672,535-264-296
Dec-20192,1592,045402447
Dec-20181,8821,788129109
Dec-20171,5361,457-243-313
Balance Sheet Summary LC

INCYTE CORPORATION - Balance Sheet Summary - in Million USD

Year Ending:Total AssetsTotal LiabilitiesTotal Equity
Dec-20225,8401,4704,370
Dec-20214,9331,1633,770
Dec-20203,5619492,611
Dec-20193,4268282,598
Dec-20182,6457201,926
Dec-20172,3016721,630
Quarterly Results Summary LC

INCYTE CORPORATION - Quarterly Results Summary - in Million USD

Quarterly Ending:Total RevenueOperating-IncomeNet Income
Dec-20229269428
Sep-2022823116112
Jun-2022911257161
Mar-202273312237.9
Dec-2021862112563
Sep-2021812238181
Founded Year
1991
Stock Exchange LC
Nasdaq